SAN DIEGO, February 3, 2021 / PRNewswire / - ViaCyte, Inc., a clinical-stage regenerative medicine company, announced today that the first patients with type...
While some countries in Asia imposed restrictions in an attempt to contain the highly contagious variant of omicron, governments in Europe, the United States,...